Characteristic brain magnetic resonance imaging abnormalities in central nervous system aquaporin-4 autoimmunity

Abstract

Background: Although neuromyelitis optica has been traditionally regarded as a disease without brain involvement, brain abnormalities are not uncommon in patients with neuromyelitis optica-related disorders.

Methods: We aimed to characterize the brain magnetic resonance imaging (MRI) abnormalities in neuromyelitis optica spectrum disorder patients who are seropositive for anti-aquaporin-4 autoantibody (AQP4 Ab). Of 236 consecutive patients with inflammatory demyelinating central nervous system diseases, we retrospectively analyzed MRI characteristics of 78 patients who were seropositive for AQP4 Ab.

Results: For an average observational period of 6.3 years, 62 patients (79%) had brain lesions on MRI. Twenty-four patients (31%) had brain MRI abnormalities at the onset of disease, and 35 (45%) had symptomatic brain involvement. Characteristic brain MRI abnormalities were classified into five categories: (1) lesions involving corticospinal tracts (e.g. posterior limb of internal capsule and cerebral peduncle (44%); (2) extensive hemispheric lesions likely due to vasogenic edema (29%); (3) periependymal lesions surrounding aqueduct and the third and fourth ventricles (22%); (4) periependymal lesions surrounding lateral ventricles (40%); and (5) medullary lesions, often contiguous with cervical lesions (31%). Fifty-four patients (69%) showed at least one kind of brain abnormality among the five characteristic MRI lesions. Ten patients showed gadolinium-enhancing lesions, which were characterized by multiple patchy enhancing patterns with blurred margins. Conclusions: In central nervous system AQP4 autoimmunity, brain MRI abnormalities were more common than is generally appreciated and were characterized by their unique localization and configuration.

Keywords

Aquaporin-4 atuoimmunity brain abnormality MRI neuromyelitis optica neuromyelitis optica spectrum disorders

Get full access to this article

View all access options for this article.

References

Lennon VA , Kryzer TJ , Pittock SJ , Verkman AS and Hinson SR IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005; 202: 473-477.

Amiry-Moghaddam M. and Ottersen OP The molecular basis of water transport in the brain. Nat Rev Neurosci 2003; 4: 991-1001.

Nielsen S. , Nagelhus EA , Amiry-Moghaddam M. , Bourque C. , Agre P. and Ottersen OP Specialized membrane domains for water transport in glial cells: high-resolution immunogold cytochemistry of aquaporin-4 in rat brain. J Neurosci 1997; 17: 171-180.

Frigeri A. , Gropper MA , Turck CW and Verkman AS Immunolocalization of the mercurial-insensitive water channel and glycerol intrinsic protein in epithelial cell plasma membranes. Proc Natl Acad Sci U S A 1995; 92: 4328-4331.

Jung JS , Bhat RV , Preston GM , Guggino WB , Baraban JM and Agre P. Molecular characterization of an aquaporin cDNA from brain: candidate osmoreceptor and regulator of water balance. Proc Natl Acad Sci U S A 1994; 91: 13052-13056.

Lennon VA , Wingerchuk DM , Kryzer TJ , et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004; 364: 2106-2112.

Pittock SJ , Lennon VA , de Seze J. , et al. Neuromyelitis optica and non organ-specific autoimmunity. Arch Neurol 2008; 65: 78-83.

Wingerchuk DM , Hogancamp WF , O’Brien PC and Weinshenker BG The clinical course of neuromyelitis optica (Devic’s syndrome). Neurology 1999; 53: 1107-1114.

Pittock SJ , Lennon VA , Krecke K. , Wingerchuk DM , Lucchinetti CF and Weinshenker BG Brain abnormalities in neuromyelitis optica. Arch Neurol 2006; 63: 390-396.

10.

Wingerchuk DM , Lennon VA , Pittock SJ , Jucchinetti CF and Weinshenker BG Revised diagnostic criteria for neuromyelitis optica. Neurology 2006; 66: 1485-1489.

11.

Nakashima I. , Fujihara K. , Miyazawa I. , et al. Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG . J Neurol Neurosurg Psychiatry 2006; 77: 1073-1075.

12.

Cabrera-Gómez JA , Quevedo-Sotolongo L. , GonzálezQuevedo A. , et al. Brain magnetic resonance imaging findings in relapsing neuromyelitis optica . Mult Scler 2007; 13: 186-192.

13.

Pittock SJ , Weinshenker BG , Lucchinetti CF , Wingerchuk DM , Corboy JR and Lennon VA Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol 2006; 63: 964-968.

14.

Bichuetti DB , Rivero RL , Oliveira DM , et al. Neuromyelitis optica: brain abnormalities in a Brazilian cohort . Arq Neuropsiquiatr 2008; 66: 1-4.

15.

Nakamura M. , Misu T. , Fujihara K. , et al. Occurrence of acute large and edematous callosal lesions in neuromyelitis optica. Mult Scler 2009; 15: 695-700.

16.

Matsushita T. , Isobe N. , Matsuoka T. , et al. Extensive vasogenic edema of anti-aquaporin-4 antibody-related brain lesions. Mult Scler 2009; 15: 1113-1117.

17.

Saiki S. , Ueno Y. , Moritani T. , et al. Extensive hemispheric lesions with radiological evidence of blood-brain barrier integrity in a patient with neuromyelitis optica. J Neurol Sci 2009; 284: 217-219.

18.

Ito S. , Mori M. , Makino T. , Hayakawa S. and Kuwabara S. ‘‘Cloud-like enhancement’’ is a magnetic resonance imaging abnormality specific to neuromyelitis optica. Ann Neurol 2009; 66: 425-428.

19.

Takahashi T. , Fujihara K. , Nakashima I. , et al. Establishment of a new sensitive assay for anti-human aquaporin-4 antibody in neuromyelitis optica. Tohoku J Exp Med 2006; 210: 307-313.

20.

Wingerchuk DM , Lennon VA , Lucchinetti CF , Pittock SJ and Weinshenker BG The spectrum of neuromyelitis optica. Lancet Neurol 2007 ; 6: 805-815.

21.

Vitali C. , Bombardieri S. , Jonsson R. , et al. Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61: 554-558.

22.

McKeon A. , Lennon VA , Lotze T. , et al. CNS aquaporin-4 autoimmunity in children . Neurology 2008 ; 71: 93-100.

23.

Lotze TE , Northrop JL , Jutton GJ , Ross B. , Schiffman JS and Hunter JV Spectrum of pediatric neuromyelitis optica. Pediatrics 2008; 122: e1039-1047.

24.

Takahashi T. , Fujihara K. , Nakashima I. , et al. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre . Brain 2007; 130: 1235-1243.

25.

Magaña SM , Matiello M. , Pittock SJ , et al. Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders. Neurology 2009; 24: 712-717.

26.

Misu T. , Fujihara K. , Nakashima I. , Sato S. and Itoyama Y. Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica. Neurology 2005; 65: 1479-1482.

27.

Takahashi T. , Miyazawa I. , Misu T. , et al. Intractable hiccup and nausea in neuromyelitis optica with anti-aquaporin-4 antibody: a herald of acute exacerbations. J Neurol Neurosurg Psychiatry 2008; 79: 1075-1078.

28.

Griesdale DEG and Honey CR Aquaporins and brain edema. Surg Neurol 2004; 61: 418-421.

29.

Nishiyama S. , Ito T. , Misu T. , et al. A case of NMO seropositive for aquaporin-4 antibody more than 10 years before onset. Neurology 2009; 72: 1960-1961.